Telephone: +44 (0)1223 750638
The Directors of Global Regulatory Services (GRS) were recently interviewed by local journalist, Mike Scialom, who was particularly intrigued in their involvement with the European Herbal Industry. The result is a feature in the July/August 2012 edition of the Cambridge Business Magazine (pages 35 to 37) entitled "Bringing
30 May 2012: Bobby Deal, Managing Director of Global Regulatory Services (GRS), is delighted to announce that GRS has become a member of the prestigious Parliamentary and Scientific Committee.
GRS, which is based near Ely, works with a global team of specialists to provide consultancy on the registration of new products, from medicinal herbal remedies and cosmetics, to the development of orphan medicinal products and new medical devices.
25 May 2012: Life science companies are missing out by not taking advance of research and development tax credits, warns Global Regulatory Services (GRS), a UK based consultancy to the life science industry.
GRS has just announced an alliance with the UK branch of the French company, Leyton, to raise awareness of the opportunities available for eligible companies.
21st May 2012: What determines whether an herbal product is registered as food, a cosmetic or for medicinal purposes?
Greer Deal, Director of Global Regulatory Services (GRS), a UK based consultancy to the life science industry, will highlight the complex regulations involved with this when she speaks at the Vitafoods Europe Conference in Geneva on Thursday 24th May 2012.
The Directors of Global Regulatory Services (GRS) are delighted to be involved the Asia-Pacific Technology Network (APTN) event being held at 17:00 in London on Tuesday 15th May:
With the current EU Cosmetics Directive becoming the Cosmetic Products Regulation, fully enforceable in July 2013, GRS can envisage that many existing and new Cosmetic companies will need support to ensure full compliance by next year's deadline. Therefore, the Directors felt it was important to link up with another like-minded consultancy who specialise in the Cosmetic Industry. With GRS' expertise in borderline products (such as herbals) and the focused specialism of CONUSBAT on Cosmetics, the combination will be of tremendous value to Cosmetic companies.
Sir Christopher Evans opened the One Nucleus Bench-to-Boardroom event on 6th March. His popularity could be seen by the fact that it was 'standing room' only for those not quick enough to capture a seat. He is often described as the ‘founding father’ of the Cambridge biotech cluster and it was clear that Cambridge remains a special place for him.
14 March 2012
New EU herbal remedy laws need urgent review, warns
Global Regulatory Services
A regulatory consultancy for the herbal industry is urging EU health officials to review new laws which came into force in April last year, warning that it is being flouted by a number of companies to avoid its costly licensing process, and that its future in Europe is at risk.
From Left to Right: Bobby Deal, Managing Director (GRS), Professor Sir Christopher Evans, Greer Deal, Director (GRS) (Photograph courtesy of Ellee Seymour, ProActive PR)
Innovative life science companies are invited to share their thoughts and experiences about research within the NHS at a One Nucleus workshop in Newmarket next month.
It will be led by Greer Deal, Director of Global Regulatory Services, who will provide examples and case studies to demonstrate how the private sector can work successfully with the public sector.
|Copyright © 2013 GRS All Rights Reserved||
Global House, Painters Lane, Sutton, Ely,
Cambridgeshire, CB6 2NS, UK
Telephone: +44(0)1223 750638